Advanced Biomed Inc. Common Stock
ADVB
Rank in Stocks
#31276
Advanced Biomed Inc. functions as an investment holding company, primarily... Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of advanced devices: A+Pre: A fully automated system designed for pre-concentrating diluted blood samples. AC-1000: A rare cell device engineered to address the challenges of detecting cells in hypercoagulable samples from tumor patients. A+SCDrop: A specialized tool for capturing individual circulating tumor cells (CTCs). A+CellScan: An analyzer featuring an immunostaining chip, utilized for the immunostaining and analysis of output from the AC-1000. Beyond standalone devices, Advanced Biomed provides microfluidic biochips, including the A+Pre, AC-1000 CTC Enrichment, and A+CellScan chips, which are integral to delivering assay products and services to cancer patients. The company also offers a comprehensive range of immunochromogenic kits: A+CTCE kit: Used to identify epithelial circulating tumor cells by detecting EpCAM, CK (pan), CD45, and CD14 antibodies. A+CTCM kit: Targets mesenchymal circulating tumor cells through their expression of Vimentin, CD45, and CD14 antibodies. A+EMT kit: Designed for the identification of epithelial-to-mesenchymal circulating tumor cells, focusing on cell-surface Vimentin, CD45, and CD14 antibodies. A+CM kit: Facilitates the detection of tumor-associated macrophages by assessing PD-L1, CD45, and CD14 antibodies. In addition to its current offerings, Advanced Biomed is actively developing A+LCGuard, a promising solution for the early screening of lung cancer. The company further expands its presence by establishing and operating medical clinics in the People's Republic of China. Founded in 2014, Advanced Biomed Inc. maintains its corporate headquarters in New York, New York.
Share Price
$2.05
Last synced: 2026-11-09
Market Cap
$3.39M
Change (1 day)
3.54%
Change (1 year)
-77.32%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Advanced Biomed Inc. Common Stock (ADVB)
Category
Healthcare
Operating Margin for Advanced Biomed Inc. Common Stock (ADVB)
Operating Margin as of November 2026 TTM: -4,984.90%
According to Advanced Biomed Inc. Common Stock's latest financial reports, its current operating margin (TTM) is -4,984.90%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Advanced Biomed Inc. Common Stock from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -4,984.90% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.00% |
US
|
|
| 20.38% | -100.00% |
US
|
|
| 43.02% | -100.01% |
CN
|
|
| 32.03% | -100.01% |
US
|
|
| 22.23% | -100.00% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Advanced Biomed Inc. Common Stock's operating margin
What is Advanced Biomed Inc. Common Stock's operating margin?
Advanced Biomed Inc. Common Stock's operating margin is -4,984.90%, as of Nov 2026.
What was Advanced Biomed Inc. Common Stock's operating margin in 2025?
In 2025, Advanced Biomed Inc. Common Stock's operating margin was 0.00%, compared with 0.00% in 2024.
How has Advanced Biomed Inc. Common Stock's operating margin changed since 2021?
From 2021 to 2025, Advanced Biomed Inc. Common Stock's operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Advanced Biomed Inc. Common Stock's operating margin compare with similar companies?
Advanced Biomed Inc. Common Stock's operating margin (-4,984.90%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.